<DOC>
	<DOCNO>NCT00824564</DOCNO>
	<brief_summary>Tranexamic acid show reduce postoperative blood loss transfusion requirement number type surgery . Most trial orthopedic surgery conduct arthroplasty , hip fracture spine surgery . This study would aim see effect tranexamic acid reduction blood loss transfusion long bone fracture surgery , primarily fracture shaft femur .</brief_summary>
	<brief_title>Study Of Tranexamic Acid For The Reduction Of Blood Loss In Patients Undergoing Surgery For Long Bone Fracture</brief_title>
	<detailed_description />
	<mesh_term>Fractures , Bone</mesh_term>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Femoral Fractures</mesh_term>
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Tranexamic Acid</mesh_term>
	<criteria>Patient undergo surgery fracture shaft femur Patients platelet count less 100 , 000/mm3 history thrombocytopenia Patients know coagulopathy Patients anemia ( hemoglobin level less 8 mg/dl hematocrit &lt; 24 % ) Patients document DVT PE screen past three month Patients know hypersensitivity tranexamic acid constituent product Patients associated major illness ( e.g. , severe cardiac respiratory disease ) Anticoagulants ( LMWH heparin prophylactic dos prevent deep vein thrombosis ) , direct thrombin inhibitor thrombolytic therapy administer complete within last week</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Tranexamic Acid</keyword>
	<keyword>Blood Loss</keyword>
	<keyword>Long Bone Fracture Surgery</keyword>
</DOC>